News ArticleSAN DIEGO (EGMN) - In the long run, standard chemotherapy alone is more effective than radiation in keeping patients with limited-stage nonbulky Hodgkin's lymphoma alive, according to updated results from an intergroup trial in 405 patients.At 12 years, 94% of patients receiving ABVD - doxorubicin (Adriamycin), bleomycin (Blenoxane), vinblastine (Velbe), and dacarbazine - chemotherapy were alive, compared with 87% receiving subtotal nodal radiation with or without chemotherapy (hazard...